Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bovine TB vaccine field trials given go-ahead
More than 40,000 cattle are slaughtered as a result of bTB infection annually.
Trials follow 20 years of research by government scientists.

Bovine TB (bTB) cattle vaccination trials have been given the go-ahead in England and Wales in a bid to develop a cattle vaccine by 2025.

The trials, which follow 20 years of research by government scientists, will be conducted over the next four years on behalf of Defra, the Welsh Government and the Scottish Government.

The UK's Chief Veterinary Officer, Christine Middlemiss, said that the research has been 'pivotal' in developing a potential vaccine.

“Whilst there is no single way to combat this damaging and complex disease, cattle vaccination is a potential new tool for our multi-pronged approach to tackle it and importantly prevent it, providing vital support to our farming communities,” she said.

“Bovine TB presents a global challenge and the UK has harnessed its world-leading science to develop potential solutions such as vaccination and new diagnostic tests that could also be valuable to other countries.”

The vaccine trials are one of several measures to eradicate bTB in England by 2038. Other measures include plans to phase out intensive badger culling in England, improve the cattle testing regime and vaccinate more badgers against the disease.

Environment Secretary George Eustice said: “Bovine TB is a slow-moving and insidious disease which can cause considerable trauma for farmers as they suffer the loss of highly prized animals and valued herds.

“This scientific breakthrough is a major step forwards in our battle to see the disease eradicated from this country. As wider preventative measures like cattle vaccines are introduced, we will accelerate other elements of our strategy and start to phase out badger culling in England, as no one wants to continue the cull of a protected species indefinitely.”

The British Veterinary Association said that the deployment of a viable cattle vaccine has the potential to be an 'absolute gamer changer.'

“These field trials mark the culmination of years of ground-breaking research and efforts by the veterinary scientific community to expand the range of tools available to vets and farmers to tackle bovine tuberculosis,” he said.

BTB is one of the most problematic animal health challenges in the UK. Every year, more than 40,000 cattle are slaughtered as a result of bTB infection.

Researchers say a vaccine could become a powerful tool in the battle against the disease following the necessary testing and efficacy approvals.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.